HENRY DOHN: Open Payments
NPI 1407857956 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,252 in 49 payments from 12 companies in 2025. Trend: 2023 $10,868 · 2024 $2,389 · 2025 $1,252
Food & beverage: $1,252
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $223 |
| Axsome Therapeutics, Inc. | 7 | $210 |
| Neurocrine BioSciences, Inc. | 10 | $209 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $170 |
| Janssen Pharmaceuticals, Inc | 2 | $127 |
| Vanda Pharmaceuticals Inc. | 5 | $112 |
| Lundbeck LLC | 4 | $77 |
| Corium, LLC | 1 | $32 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $27 |
| Tonix Medicines, Inc. | 1 | $24 |
Products named: REXULTI, INGREZZA, CAPLYTA, Sunosi, SPRAVATO, FANAPT, Auvelity, Azstarys.
Industry payments across FL — which companies pay providers there.
